Cancer researchers warn US budget cuts block advances

June 1, 2013

Cancer researchers warned Friday that federal budget cuts enacted by the US Congress could block key advances in the fight against deadly disease.

"Draconian cuts to biomedical research will slow our progress at the moment of greatest scientific potential and increasing need worldwide," Dr. Sandra Swain, president of the , said at the opening of the group's annual meeting.

The National Institutes of Health's budget has been slashed by 20 percent and is now at its lowest level since 2001, Swain said.

That funding needs to be restored if researchers are going to be able to expand on the significant progress made in recent years developing new treatments and diagnostic tools.

More than 7.6 million people worldwide will die from cancer this year and that number is expected to rise to over 12 million by 2030.

In addition to undermining more , the cuts could also limit the number of able to participate in clinical trials which could extend their lives.

"Even before the most recent budget cuts our clinical research didn't have the strong federal funding it needed," Swain told reporters.

"Our federally funded clinical trials system has achieved remarkable advances that have improved survival and quality of life for millions of people with cancer, but this progress is occurring under the cloud of slashing."

Public spending on US clinical trials for come in at around $243 million a year while pharmaceutical companies spend $6 billion, said Monica Bertagnolli, chair of the Alliance for Clinical Trials in Oncology.

" is not just drugs," Bertagnolli said, warning that important but "unprofitable" areas of research are not being sufficiently pursued.

Some 30,000 cancer specialists are expected to attend the society's annual meeting in Chicago, where over 4,700 studies will be presented.

Related Stories

New therapy is tolerable in lung cancer

May 31, 2013

A promising new therapy for the most common form of lung cancer appears to produce largely manageable side effects, and an ongoing clinical trial is determining whether the compound treats tumors more effectively than what's ...

Recommended for you

New treatment options for a fatal leukemia

July 27, 2015

In industrialized countries like in Europe, acute lymphoblastic leukemia is the most common form of cancer in children. An international research consortium lead by pediatric oncologists from the Universities of Zurich and ...

Exciting results from cancer immunoagent study

July 20, 2015

(Medical Xpress)—Cancer therapies have improved incrementally over the years, but cancer treatment largely remains analogous to forest fire suppression, in which the spread of fire is contained with deliberate controlled ...

Modified DNA building blocks are cancer's Achilles heel

July 22, 2015

In studying how cells recycle the building blocks of DNA, Ludwig Cancer Research scientists have discovered a potential therapeutic strategy for cancer. They found that normal cells have highly selective mechanisms to ensure ...

1 comment

Adjust slider to filter visible comments by rank

Display comments: newest first

Shootist
1 / 5 (1) Jun 01, 2013
Cancer researchers warn US budget cuts block advances

Uh, then get the Canadians to pay for it. Or the British, Russians and Germans.

America isn't the only rich tasting teat in the barnyard.

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.